🔎 Trials Near Me

Beranda › Kolitis Ulseratif › California

Uji klinis Kolitis Ulseratif di California

40 studi untuk Kolitis Ulseratif mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Clinnova Research /ID# 280509, Anaheim
  • Southern California Res. Ctr /ID# 280476, Coronado
  • Gastro Care Institute /ID# 281071, Lancaster
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology and Liver Institute, Escondido
  • United Clinical Research Institute, Murrieta
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • Rady Children's Hospital /ID# 271873, San Diego
  • University of California San Francisco - Mission Bay /ID# 273022, San Francisco
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07071519

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
  • Southern California GI and Liver Centers (SCLC), Coronado
  • Valley View Research, Garden Grove
  • dan 6 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Palo Alto
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 024, Canoga Park
  • Site 023, La Jolla
  • Site 012, Lancaster
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-018, San Diego
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Clinnova Research ( Site 1042), Anaheim
  • Southern California Research Center ( Site 1044), Coronado
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Gastro Care Institute, Lancaster
  • Medical Associates Research Group, Inc., San Diego
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Southern California Research Center, Coronado
  • Om Research LLC, Lancaster
  • dan 7 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Loma Linda University Health System, Loma Linda
  • Cedars-Sinai Medical Center, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
  • dan 1 lainnya
Menerima pesertaFase 2/3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • UCSF Medical Center at Mission Bay, San Francisco
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Clinnova Research - Anaheim, Anaheim
  • Om Research LLC, Lancaster
  • Biopharma Informatic, LLC, Los Angeles
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • GMC Clinical Research, Folsom
  • Om Research LLC, Temple City
  • dan 1 lainnya
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • Cedars-Sinai Medical Center, Los Angeles
  • Hoag Hospital Newport Beach, Newport Beach
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • United Medical Doctors CA - Site Number: 8400044, Murrieta
  • Om Research, LLC - Victorville - Site Number: 8400022, Victorville
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Gastro SB Clinic, Chula Vista
  • United Medical Doctors, Los Alamitos
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
  • Alliance Research Institute - Site Number: 8400008, Canoga Park
  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • dan 13 lainnya
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07184996

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

  • Vanda Investigational Site, Chula Vista
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07686081

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

  • Cedars Sinai Medical Center, Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07034443

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Hoag Hospital, Irvine
  • UC San Diego Health, La Jolla
  • Cedars-Sinai, Los Angeles
  • dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Gastroenterology Medical Clinic (Objective Health), Folsom
  • Center for Colorectal Innovation, Los Angeles
  • Hoag Hospital, Newport Beach
  • dan 1 lainnya
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06571669

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Children's Hospital Of Orange County, Orange
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06100289

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Scripps Clinic Torrey Pines, La Jolla
  • United Medical Doctors, Los Alamitos
  • United Medical Doctors, Los Alamitos
Menerima pesertaStudi observasional
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Valley View Wellness Medical Center, Garden Grove
  • Loma Linda Children's Hospital, Loma Linda
  • Loma Linda University Clinical Trial Center, Loma Linda
  • dan 7 lainnya
Menerima pesertaFase 2
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Loma Linda University, Loma Linda
  • Children's Hospital of Orange County, Orange
  • Stanford Children's Health, Palo Alto
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06405087

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

  • Amicis Research Center, Valencia
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05666960

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

  • Children's Hospital Los Angeles, Los Angeles
Menerima pesertaFase 2
Usia 7 hingga 21 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05218850

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Rady Children's Hospital - San Diego - PIN, San Diego
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT05442567

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

  • Investigational Site Number: 8400009, Escondido
  • Investigational Site Number: 8400006, Lancaster
  • Investigational Site Number: 8400025, Thousand Oaks
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06975722

Fermented Food-Supplemented Diet in Ulcerative Colitis

  • Stanford University, Palo Alto
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT04401605

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

  • Stanford University, Palo Alto
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT03615690

Impact of Prebiotics in Ulcerative Colitis

  • UCLA, Los Angeles
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06495658

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • University of Los Angeles Health, Los Angeles
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT05987852

Effects of Pomegranate Juice on Ulcerative Colitis

  • West Los Angeles VA Medical Center, Los Angeles
  • UCLA Center for Human Nutrition, Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Des 2025 · NCT07115862

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

  • Bausch Health Site 008, Garden Grove
Menerima pesertaFase 4
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 16 Sep 2025 · NCT04314375

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

  • University of California San Diego, La Jolla
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 16 Mei 2023 · NCT04721873

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.